2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis-Reference-Cited by-同舟云学术

2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis

Published:2016-06 Issue: Volume:115 Page:14-25
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Shukla Lena,Ajram Laura A.,Begg Malcolm,Evans Brian,Graves Rebecca H.,Hodgson Simon T.,Lynn Sean M.,Miah Afjal H.,Percy Jonathan M.,Procopiou Panayiotis A.,Richards Stephen A.,Slack Robert J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference51 articles.

1. Targeting chemokine receptors in chronic inflammatory diseases: An extensive review

2. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma

3. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics

4. Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease

5. CCR4-dependent regulatory T cell function in inflammatory bowel disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collaborative GSK–University of Strathclyde doctoral research and training programmes: Transforming approaches to industry–academia engagement;Drug Discovery Today;2024-09

2. Design, synthesis, and bioevaluation of diarylpyrimidine derivatives as novel microtubule destabilizers;Frontiers in Chemistry;2024-07-25

3. Exploring an Intracellular Allosteric Site of CC-Chemokine Receptor 4 from 3D Models, Probe Simulations, and Mutagenesis;ACS Pharmacology & Translational Science;2024-07-16

4. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments;Antibodies;2024-04-22

5. The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine;Frontiers in Pharmacology;2020-08-28